Financial & Business, OEM News

Presbia Acquires Neoptics’ Comprehensive Patent Portfolio

Now the only corneal implant company with intellectual property for near-vision correction with a powered micro-lens.

Presbia PLC, an ophthalmic device company and leader in near-vision restoration, announced that on August 2, 2016, its wholly-owned subsidiary, Presbia Ireland, Ltd., completed the purchase of the assets of Neoptics AG (“Neoptics”), including its intellectual property portfolio.
 
“The acquisition of Neoptics’ assets, including its patent portfolio, consolidates the principal intellectual property (‘IP’) and ‘know-how’ underpinning the use of an optically powered micro-lens for the correction of presbyopia (near-vision loss), a condition affecting 1.8 billion people globally. This consolidation of IP and know-how from Presbia and Neoptics has also created a patent protected platform to deploy our ‘micro-lens’ technology into solutions for vision problems beyond presbyopia, significantly expanding our addressable market into the future,” said Todd Cooper, President and CEO of Presbia.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters